BOSTON, Oct 04, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) (the Company) today announced the
launch of a new spinal deformity correction module based on the
successful Firebird(TM) pedicle screw system which its Spinal
Implants Division introduced last year.
"With our new deformity correction system we are now able to provide our
surgeon customers with a state-of-the-art treatment option for their
patients suffering from conditions such as scoliosis and kyphosis," said
Alan Milinazzo, President and CEO of Orthofix. "This is an important
addition to our broad portfolio of spinal implants, one that improves
our competitive position in the spine market."
The unique design of the system's new Direct Vertebral Rotation (DVR)
device provides surgeons with the opportunity to combine rod reduction
and direct vertebral rotation in one low profile instrument, and is also
intended to provide quicker intraoperative assembly and disassembly when
compared to other deformity correction systems available. The new
Firebird deformity correction module is currently in limited market
release, and Orthofix expects to begin its full market release during
the first quarter of 2011.
The portion of the U.S. spinal deformity correction market that
Orthofix's new device is designed to address is estimated to be
approximately $500 million annually.
Orthofix will feature its new deformity correction system during its
attendance at the upcoming 2010 North American Spine Society (NASS)
conference on Orlando, FL starting on October 5th. During the
conference the Company will also provide several clinical and surgical
presentations. The schedule of these presentations is available at http://www.orthofix.com/hcp/nass.asp.
About Orthofix
Orthofix International, N.V. is a global medical device company offering
a broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages-helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
including BREG, Inc. and via partnerships with other leading orthopedic
product companies. In addition, Orthofix collaborates with leading
medical institutions such as the Musculoskeletal Transplant Foundation,
the Orthopedic Research and Education Foundation, and The University of
Medicine and Dentistry of New Jersey. For more information about
Orthofix, please visit www.orthofix.com.
SOURCE: Orthofix International, N.V.
Orthofix International, N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com
Copyright Business Wire 2010